BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 101.44% institutional investors, 0.35% insiders. Blackrock is the largest institutional shareholder, holding 12.04% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.05% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical101.44%0.35%-1.78%
SectorHealthcare Stocks 50.44%12.38%37.18%
IndustryBiotech Stocks 48.97%12.07%38.96%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.74M12.04%$1.87B
Blackrock funding, inc. /de20.45M10.62%$1.17B
Vanguard group18.13M9.46%$1.08B
Dodge & cox14.84M7.71%$849.43M
Primecap management co/ca/14.19M7.37%$811.96M
Vanguard capital management8.74M4.54%$500.31M
Norges bank8.21M4.26%$469.66M
State street7.80M4.05%$446.37M
Viking global investors lp7.62M3.96%$435.82M
Vestal point capital, lp6.03M3.13%$344.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management524.79K11.41%$30.03M
Vestal point capital, lp6.03M8.06%$344.75M
Boone capital management583.22K7.81%$33.37M
Eagle health investments lp624.68K5.92%$35.74M
Palo alto investors lp682.78K5.40%$39.07M
Sector gamma as294.92K3.66%$16.88M
Camber capital management lp600.00K3.10%$32.98M
Motley fool wealth management3.53K3.07%$202.16K
Deep track capital, lp3.31M2.75%$189.25M
Sphera funds management328.55K2.45%$18.80M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank8.21M0.05%8.21M
Vestal point capital, lp6.03M8.06%2.45M
Deep track capital, lp3.31M2.75%2.16M
Sixth street partners management company1.62M0.01%1.62M

Top Sellers

HolderShares% AssetsChange
Elliott investment management---3.50M
Citadel advisors1.12M0.01%-3.39M
Aqr capital management5.70M0.11%-1.98M
Avoro capital advisors---1.46M
Point72 asset management---1.20M

New Positions

HolderShares% AssetsChangeValue
Norges bank8.21M0.05%8.21M$469.66M
Sixth street partners management company1.62M0.01%1.62M$92.47M
Arga investment management, lp1.04M1.52%1.04M$59.47M
Hotchkis & wiley capital management447.20K0.07%447.20K$25.59M
Axa investment managers362.95K0.05%362.95K$19.66M

Sold Out

HolderChange
Elequin securities-1.00
Blume capital management-2.00
Curio wealth-2.00
Householder group estate & retirement specialist-3.00
Raleigh capital management-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20265830.17%195,263,3706.32%1011.11%292-4.58%19318.40%
Mar 31, 2026328-42.35%61,195,485-67.48%310.33%168-35.88%86-60.37%
Dec 31, 2025386-36.30%120,381,244-32.95%620.71%173-43.09%149-25.13%
Sep 30, 2025521-13.60%148,245,021-13.91%770.96%255-20.56%182-1.62%
Jun 30, 2025611-0.97%183,457,4080.41%951.05%322-5.57%1886.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.05%-
American Funds Growth Fund of Amer A8.28M4.32%741.56K
Capital Group Growth Fnd of Amer Comp8.28M4.32%741.56K
iShares Core S&P Mid-Cap ETF6.64M3.43%204.00
Vanguard Morn Total Stk Mkt Idx Investor6.14M3.18%17.09K
Vanguard Total Stock Mkt Idx Inv6.14M3.18%17.09K
Vanguard US Total Market Shares ETF6.04M3.15%4.43K
Vanguard Capital Opportunity Inv5.17M2.67%72.50K
Vanguard PRIMECAP Inv4.97M2.57%-201.00K
Capital Group AMCAP Composite4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
May 07, 2026Friberg Gregory R EVP, Chief R&D OfficerSell$176.68K
Mar 11, 2026Guyer Charles Greg EVP, Chief Technical OfficerSell$996.74K
Feb 26, 2026Friberg Gregory R EVP, Chief R&D OfficerSell$381.94K
Feb 26, 2026Davis George Eric EVP, Chief Legal OfficerSell$1.60M
May 20, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$105.93K

Insider Transactions Trends


DateBuySell
2026 Q2-1
2026 Q1-3
2025 Q4--
2025 Q3--
2025 Q2-2

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 101.44%, followed by 0.35% insiders and -1.79% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 48.97%, which BioMarin Pharmaceutical exceeds.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock (22.74M shares, 12.04%), Blackrock funding, inc. /de (20.45M shares, 10.62%), and Vanguard group (18.13M shares, 9.46%). Together, they hold 32.12% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 11.41% of its assets in 524.79K BioMarin Pharmaceutical shares, valued at 30.03M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.05% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools